Allyson Fortis, APRN
Adult Health · Orlando, FLNPI 1174110092
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $359 of the $442 with a category attached, or 81.2%. It is spread thinly across 14 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for adult health clinicians in FL, where the typical reported total is $505.
Across 20 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$103
- Daiichi Sankyo Inc.$66
- Novartis$58
- Sanofi$39
- Gilead$23
- Bayer$21
- plus $132 from 8 others
What the payments were for
- Food & beverage$35981%
- Education$8319%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 2 | $103 |
| Daiichi Sankyo Inc. | 3 | $66 |
| Novartis | 3 | $58 |
| Sanofi | 2 | $39 |
| Gilead | 1 | $23 |
| Bayer | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
| AstraZeneca | 1 | $18 |
| G1 Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Morphosys, US Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $12 |
| Seagen Inc. | 1 | $12 |
How this compares
$442 in reported general payments places this provider in the 45th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 122 | $832 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 30 | $184 |
| Amlodipine Besylate | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other adult health in Orlando
- Sita SwamyOrlando$49K
- Andreina NeallOrlando$16K
- Jessica SettineriOrlando$14K
- Kristen KessingerOrlando$13K
- Angelo LewisOrlando$12K
- Patricia PagnottaMaitland$409K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.